Covalis Capital’s Axogen AXGN Stock Holding History

Covalis Capital’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$331K	–	107
2026 Q1	$331K	Buy	+10,000	New	+$325K	0.02%	115

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Covalis Capital's AXGN Position: Q2 2026 in Review

Covalis Capital sold out of Axogen (AXGN) in Q2 2026, closing a stake of 10,000 shares — an estimated $331K sold.

Covalis Capital first reported a position in AXGN in Q1 2026 and held it in 1 quarter. The position peaked at $331K in Q1 2026. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Covalis Capital reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
Covalis Capital sold 10,000 Axogen shares in Q2 2026, an estimated $331K.
Covalis Capital first reported a position in Axogen in Q1 2026 and held it in 1 quarter.
Covalis Capital's Axogen position peaked at $331K in Q1 2026.
253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Covalis Capital's 13F filing for Q2 2026, filed 13 Aug 2026.